Biofire Joint Infection (JI) Panel

The Biofire Joint Infection (JI) Panel test is carefully performed at our center to ensure precise and reliable results. The BioFire joint infection panel also known as BJI Panel test, enhances joint infection diagnosis by providing reliable results and detects a range of pathogens and antimicrobial resistance gene targets via synovial fluid sample testing. The Biofire Panel is performed using a FDA-Approved Biofire System by Rapid Multiplex PCR method which produces an average of 91.7% sensitivity and 99.8% specificity for pathogens, with a same-day reporting TAT for samples collected before 11AM at HOD.